Trial Profile
An open-label, non-randomized phase I/II trial of neoadjuvant radio-immunochemotherapy with cetuximab and 5-FU for advanced rectal cancer
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 15 Dec 2015
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Fluorouracil
- Indications Rectal cancer
- Focus Adverse reactions; Therapeutic Use
- 15 Dec 2015 New trial record